Search - tctmd.com

Displaying 181 - 200 of 303

Sort: Relevancy | Date

News Daily News

PROMISE Analysis Boosts Gatekeeper Role for FFRCT in Symptomatic Stable CAD

Shelley Wood

April 12, 2017

News Daily News

Using Coronary CTA to Evaluate Suspected CAD May Improve Patient Outcomes

Todd Neale

April 03, 2017

News Conference News ACC 2017

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

Michael O'Riordan

March 18, 2017

News Daily News

‘Hub and Spoke’ Model Promises to Improve Access to PCI for STEMI in Low- and Middle-Income Countries

L.A. McKeown

March 14, 2017

News Daily News

Mixed Clinical, Biomarker Score Might Boost CAD Risk Prediction

Yael L. Maxwell

March 03, 2017

News Daily News

Edward ‘Ted’ Diethrich, Founder of the Arizona Heart Institute, Dies at 81

L.A. McKeown

March 01, 2017

News Daily News

Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds?

Michael O'Riordan

February 02, 2017

News Daily News

TWENTE: Resolute and Xience Stents Show Comparable Outcomes up to 5 Years

Michael O'Riordan

January 20, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2016

Shelley Wood

November 30, 2016

News Conference News TCT 2016

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

Yael L. Maxwell

October 31, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2016

Caitlin E. Cox

September 01, 2016

News Conference News ESC 2016

Another Meeting, Another Mesenchymal Stem Cell Study (or Two), With Mixed Results

Shelley Wood

August 28, 2016

News Industry News

Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin

August 25, 2016

News Features

The Bioresorbable Stent Story So Far: What Promise? What Price?

Michael O'Riordan

August 17, 2016

News Daily News

Television Viewing Time Linked to Higher Mortality From Pulmonary Embolism

L.A. McKeown

July 25, 2016

News Daily News

Studies Provide More Support for High-Sensitivity Troponin Testing to Speed Triage of Patients With Suspected ACS

Todd Neale

June 02, 2016

News Daily News

Anti-Inflammatory Drug Does Not Halt Plaque Progression in Overweight Patients With CAD

Todd Neale

May 27, 2016

News Daily News

SYNTAX Score II Added to Modern PCI Translates Into Gains for Patients With Three-Vessel Disease

Caitlin E. Cox

May 26, 2016

News Daily News

对疑似 CAD 病例，CTA 在临床和经济上都与功能测试具有可比性

Leah Lawrence

May 25, 2016

News Daily News

La ATC es Parecida tanto Clínica como Económicamente a las Pruebas Funcionales para Descartar EAC

Leah Lawrence

May 25, 2016

Advertisement

PROMISE Analysis Boosts Gatekeeper Role for FFRCT in Symptomatic Stable CAD

Using Coronary CTA to Evaluate Suspected CAD May Improve Patient Outcomes

ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience

‘Hub and Spoke’ Model Promises to Improve Access to PCI for STEMI in Low- and Middle-Income Countries

Mixed Clinical, Biomarker Score Might Boost CAD Risk Prediction

Edward ‘Ted’ Diethrich, Founder of the Arizona Heart Institute, Dies at 81

Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds?

TWENTE: Resolute and Xience Stents Show Comparable Outcomes up to 5 Years

TCTMD’s Top 10 Most Popular Stories for November 2016

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

TCTMD’s Top 10 Most Popular Stories for August 2016

Another Meeting, Another Mesenchymal Stem Cell Study (or Two), With Mixed Results

Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin

The Bioresorbable Stent Story So Far: What Promise? What Price?

Television Viewing Time Linked to Higher Mortality From Pulmonary Embolism

Studies Provide More Support for High-Sensitivity Troponin Testing to Speed Triage of Patients With Suspected ACS

Anti-Inflammatory Drug Does Not Halt Plaque Progression in Overweight Patients With CAD

SYNTAX Score II Added to Modern PCI Translates Into Gains for Patients With Three-Vessel Disease

对疑似 CAD 病例，CTA 在临床和经济上都与功能测试具有可比性

La ATC es Parecida tanto Clínica como Económicamente a las Pruebas Funcionales para Descartar EAC

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content